Impact of Coding Variation on Transcription Factor - DNA Recognition

编码变异对转录因子 - DNA 识别的影响

基本信息

  • 批准号:
    10368951
  • 负责人:
  • 金额:
    $ 79.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-05-01 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

ABSTRACT Binding by sequence-specific transcription factors (TFs) to their recognition sites is a primary step in gene regulation. In-depth characterization of the DNA binding specificities of TFs is essential for understanding how transcriptional regulation is specified. Technologies developed in the past decade for highly parallel analysis of TF DNA binding specificities have been used to survey the DNA binding specificities of TFs from a variety of TF DNA binding domain (DBD) structural classes (e.g., homeodomains) and species. Nevertheless, despite the generation of these large datasets, a detailed understanding of TF-DNA binding specificity determinants is still lacking for most TFs. Disease mutations and naturally occurring coding variation in TFs, especially those within DBDs, have the potential to alter TF DNA binding activity. However, there is insufficient understanding of the determinants of TF-DNA binding activity to allow for accurate prediction of the effects of such coding mutations on DNA binding activity. This is an important problem, since mutations or coding variation that damage TF DNA binding activity have the potential to disrupt the regulation of 1,000s of genes in the human genome. The goals of this project are to investigate novel DNA binding activity determinants for major structural classes of human TFs, to determine how heterodimeric protein partners might modulate the effects of TF coding variants on DNA binding activity, and to determine the extent to which coding variation that damages intrinsic TF-DNA recognition alters TF genomic targeting and gene regulation. We anticipate our results and datasets will reveal determinants of TF-DNA binding specificity, identify what mutations damage DNA binding specificity or affinity, inform future interpretations of exome and whole-genome sequence data, and open new areas of investigation into studies of how TF coding variation impacts transcriptional gene regulation and human phenotypes.
摘要 序列特异性转录因子(TF)与其识别位点的结合是一种 基因调控的第一步。DNA结合的深入表征 转录因子的特异性对于理解转录调控是如何 指定的.过去十年发展的TF高度并行分析技术 DNA结合特异性已被用于调查TF的DNA结合特异性 从多种TF DNA结合结构域(DBD)结构类别(例如,同源结构域) 和物种。然而,尽管产生了这些大型数据集, 对于大多数TF,仍然缺乏对TF-DNA结合特异性决定簇的理解。 疾病突变和TF中自然发生的编码变异,特别是那些 在DBD中,具有改变TF DNA结合活性的潜力。不过有 对TF-DNA结合活性的决定因素了解不足, 准确预测这种编码突变对DNA结合活性的影响。这 是一个重要的问题,因为突变或编码变异, 结合活性有可能破坏1,000个基因的调控, 人类基因组 本项目的目标是研究新的DNA结合活性决定簇, 主要结构类别的人TF,以确定如何异二聚体蛋白伴侣 可能调节TF编码变体对DNA结合活性的影响, 确定编码变异破坏内在TF-DNA的程度 识别改变TF基因组靶向和基因调控。我们预计我们的结果 数据集将揭示TF-DNA结合特异性的决定因素, 突变损害DNA结合特异性或亲和力,为未来的解释提供信息。 外显子组和全基因组序列数据,并开辟了新的研究领域, 研究TF编码变异如何影响转录基因调控和人类 表型

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARTHA L BULYK其他文献

MARTHA L BULYK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARTHA L BULYK', 18)}}的其他基金

Influences of DNA sequence and histone features on transcription factor binding to nucleosomes
DNA 序列和组蛋白特征对转录因子与核小体结合的影响
  • 批准号:
    10528812
  • 财政年份:
    2022
  • 资助金额:
    $ 79.06万
  • 项目类别:
Influences of DNA sequence and histone features on transcription factor binding to nucleosomes
DNA 序列和组蛋白特征对转录因子与核小体结合的影响
  • 批准号:
    10688104
  • 财政年份:
    2022
  • 资助金额:
    $ 79.06万
  • 项目类别:
Transcription factor mutationsunderlying birth defects or pediatric cancers
出生缺陷或儿科癌症背后的转录因子突变
  • 批准号:
    9807965
  • 财政年份:
    2019
  • 资助金额:
    $ 79.06万
  • 项目类别:
Transcription factor mutationsunderlying birth defects or pediatric cancers
出生缺陷或儿科癌症背后的转录因子突变
  • 批准号:
    10004146
  • 财政年份:
    2019
  • 资助金额:
    $ 79.06万
  • 项目类别:
Impact of Coding Variation on Transcription Factor - DNA Recognition
编码变异对转录因子 - DNA 识别的影响
  • 批准号:
    10112946
  • 财政年份:
    2019
  • 资助金额:
    $ 79.06万
  • 项目类别:
Impact of Coding Variation on Transcription Factor - DNA Recognition
编码变异对转录因子 - DNA 识别的影响
  • 批准号:
    9923713
  • 财政年份:
    2019
  • 资助金额:
    $ 79.06万
  • 项目类别:
Impact of Coding Variation on Transcription Factor - DNA Recognition
编码变异对转录因子 - DNA 识别的影响
  • 批准号:
    10561151
  • 财政年份:
    2019
  • 资助金额:
    $ 79.06万
  • 项目类别:
AVATAR: highly parallel analysis of variation in transcription factors and their DNA binding sites
AVATAR:转录因子及其 DNA 结合位点变异的高度并行分析
  • 批准号:
    9767247
  • 财政年份:
    2018
  • 资助金额:
    $ 79.06万
  • 项目类别:
Rewiring of regulatory networks in breast cancer by transcription factor isoforms
转录因子同工型对乳腺癌调控网络的重新布线
  • 批准号:
    10249199
  • 财政年份:
    2018
  • 资助金额:
    $ 79.06万
  • 项目类别:
Surveying transcription factor pioneer interactions with nucleosomal DNA
调查转录因子先锋与核小体 DNA 的相互作用
  • 批准号:
    9360141
  • 财政年份:
    2016
  • 资助金额:
    $ 79.06万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 79.06万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 79.06万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 79.06万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 79.06万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 79.06万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 79.06万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 79.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 79.06万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 79.06万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 79.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了